| Volume | 50,209 |
| Open | 8.060 |
| Bid (Size) | 7.850 (200) |
| Ask (Size) | 7.910 (400) |
| Prev. Close | 8.160 |
| Today's Range | 7.780 - 8.150 |
| 52wk Range | 7.490 - 73.06 |
| Shares Outstanding | 54,462,518 |
| Dividend Yield | N/A |
Atrium Therapeutics, Inc. - Common Stock (RNA) traded between $7.49 and $73.06 over the past 52 weeks and last traded at $7.91, 89.2% below its 52-week high. Over the past week it ranged between $7.49 and $8.32.
RNA was -83.1% over the past year, -42.9% over six months, -89.0% year to date, +3.1% in the last week.
Over the past 12 months RNA returned -83.1% versus DIA (Dow) +12.2%, SPY (S&P 500) +14.2%, QQQ (Nasdaq 100) +17.0% and IWM (Russell 2000) +13.3%.
RNA most recently traded 50,209 shares against a 3-month average daily volume of 280.5K.
© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.